HHS regulatory reform committee
This article was originally published in The Gray Sheet
Executive Summary
Secretary Thompson's advisory panel meeting, originally scheduled for Oct. 1, will likely occur in mid-November. The meeting was postponed to allow for completion of the panel's report to the secretary...
You may also be interested in...
HHS regulatory reform committee
Secretary Thompson's advisory panel on regulatory reform will convene its final meeting Nov. 21 in Washington, D.C. The meeting was postponed from Oct 1-2 to allow more time for the panel to complete its final report to the secretary (1"The Gray Sheet" Sept. 30, 2002, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.